Episode 54
Biotech Hangout
00:00
Sedara Therapeutics Gets FDA Approval for an Antifungal Drug
We have a license agreement with Karina because we invented the program. So we have royalties of 3% which are flat. But the deal that we did with royalty pharma gives us, you know, once the revenues hit a certain threshold, which is $2 billion, we then get back 67% of the royalties. In this case, it's flat, but we get a bigger share of it. We also get a sub-license payment when they do any deals. Sure. Sedara Therapeutics got FDA approval for their antifungal drug. Rob, I would love to hear your thoughts on the approval and also just broadly the need for antifungals, ant
Transcript
Play full episode
